Rockwell Medical, Inc. (NASDAQ:RMTI) stock rose Tuesday after the company announced preliminary results for the three months and twelve months ended December 31, 2025.
The company said fourth-quarter sales are expected to total approximately $18.6 million, exceeding the Street consensus estimate of $16.55 million. Full-year revenue is projected to come in near $69.5 million.
The company expects the fourth-quarter 2025 gross margin …